Regulations last checked for updates: Nov 22, 2024

Title 16 - Commercial Practices last revised: Nov 20, 2024
§ 1702.16 - Petitions requesting an exemption for a drug or a new drug.

(a) Where the petition requests an exemption for a drug, as defined in section 201(g)(1) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321(g)(1), the petitioner shall include those reports required to be filed under the Food and Drug Administration's Adverse Reaction Reporting Program.

(b) [Reserved]

[45 FR 13064, Feb. 28, 1980, as amended at 66 FR 40115, Aug. 2, 2001]
authority: 15 U.S.C. 1471(4), 1472, 1474, 1269(a), 2079(a); 21 U.S.C. 371(a)
source: 45 FR 13064, Feb. 28, 1980, unless otherwise noted.
cite as: 16 CFR 1702.16